Hepatitis is often called the silent killer because globally 95{ddf8d179d1bf712bb2a88ff2ad95ebdf63eaa5463c845d2f093b25848387ba96} of people with hepatitis are unaware of their infection as most sufferers show no symptoms. Over 13 million people in the European Region are estimated to be living with hepatitis B virus (HBV) infection, and over 15 million with chronic hepatitis C virus (HCV) infection. […]
Hepatitis – the “silent killer” Read More »
Agriculture and health are intimately connected according to ‘Agriculture and public health: impacts and pathways for better coherence‘ by the European Public Health Alliance. However, health is usually a ‘missing link’ in the agricultural debate, partly because the multifaceted interactions between health and agriculture are rarely fully recognised. This discussion paper summarizes the wide-ranging impacts
Agriculture and Public Health Read More »
The online database ‘OECD health statistics 2016‘ has been released and offers the most comprehensive source of comparable statistics on health and health systems across OECD countries. It is an essential tool to carry out comparative analyses and draw lessons from international comparisons of diverse health systems. It includes data on biotechnology, cancer, health care,
OECD Health Statistics 2016 Read More »
The OECD has just published ‘Better ways to pay for health care‘ as part of their Health Policy Studies series. This publication points out that payers for health care are trying a variety of policies as part of broader efforts to improve the quality and efficiency of care. Any reform requires other measures to be
Better Ways to Pay for Health Care Read More »
The health sector represents 10{ddf8d179d1bf712bb2a88ff2ad95ebdf63eaa5463c845d2f093b25848387ba96} of the EU’s GDP and accounts for 8{ddf8d179d1bf712bb2a88ff2ad95ebdf63eaa5463c845d2f093b25848387ba96} of the total European workforce. It is a vital economic sector strongly driven by innovation and is a growth-friendly area for investment. The European Fund for Strategic Investments (EFSI) can support investment in innovative health solutions, new effective medicines and social infrastructures.
Investing in innovative health solutions Read More »
An international tribunal has upheld the sovereign authority of states to protect health through tobacco control. The World Bank’s International Centre for Settlement of Investment Disputes (ICSID) has confirmed that tobacco control measures applied by the Government of Uruguay did not violate the terms of an investment agreement between Uruguay and Switzerland, under which the
Protecting health through tobacco control Read More »
The Dutch health system has been undergoing transformational reform since the mid-2000s. The 2006 reform introduced managed competition as a driving mechanism in health care. Ten years of gradual implementation have changed and continue to change the health care system and the role of stakeholders. A second major reform in long term care (2015) aimed
Reforming Dutch long-term care Read More »
The European Health Parliament is a platform of 55 young professionals from across Europe, which aims to deliver high-level policy-oriented recommendations to positively influence and change the future of healthcare in Europe. It has just published ‘Rethinking European Healthcare: recommendations by the next generation’. It covers proposals on: antimicrobial resistance climate change and health digital
Rethinking European health care Read More »
All populations will be affected by climate change, but some are more vulnerable than others. In Europe it will be people living on small islands, in coastal regions and on rivers who will be particularly vulnerable. WHO have produced a fact sheet on climate change and health which provides key facts, outlines patterns of infection,
Climate change and health Read More »
Global consumption of antibiotics in human medicine rose by nearly 40{ddf8d179d1bf712bb2a88ff2ad95ebdf63eaa5463c845d2f093b25848387ba96} in the decade from 2000 and in 2007 25,000 people a year in the EU were dying from an infection due to antibiotic-resistant bacteria. Infections due to these multi-drug resistant bacteria are estimated to cost the EU at least €1.5 billion a year in
Need for greater EU action on antimicrobial resistance Read More »
